PHARMACOKINETICS OF TOTAL AND FREE VALPROIC ACID DURING MONOTHERAPY IN INFANTS

被引:13
|
作者
HERNGREN, L [1 ]
LUNDBERG, B [1 ]
NERGARDH, A [1 ]
机构
[1] KAROLINSKA HOSP,DEPT PAEDIAT,S-10401 STOCKHOLM 60,SWEDEN
关键词
VALPROIC ACID; INFANTS; PROTEIN BINDING; PHARMACOKINETICS;
D O I
10.1007/BF00315328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pharmacokinetics of free and total valproic acid (VPA) in plasma and whole blood after oral administration during steady state was investigated in seven infants (mean age 10.7 months) receiving monotherapy. The VPA concentrations in whole blood closely followed those in plasma but at a reduced level. A positive correlation was found between dose and mean plasma concentration (r = 0.71). Mean terminal half-lives were similar in plasma and whole blood (12.5 and 15.5 h, respectively), but were considerably longer than for free VPA (6.4 and 6.5 h, respectively; P < 0.01). There was a significant decrease in half-lives with increasing age (P < 0.05). Plasma and whole blood clearance for total VPA was higher than reported in older infants and adults (17.8 and 28.9 ml/kg per hour) and was considerably higher for free VPA (127.6 and 188.8 ml/kg per hour, respectively). The increase in clearance compared with that in older subjects is well in concordance with a lower protein binding of VPA (mean 85.3%). Of special importance is that the percentage of unbound VPA increased with increasing concentrations of total VPA. The fraction of unbound VPA in plasma increased even more in subjects with low albumin concentrations (P < 0.01).
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [1] Pharmacokinetics of total and free valproic acid during bitherapy with lamotrigine or vigabatrin in epileptic children and adolescents
    Steinborn, B
    Galas-Zgorzalewicz, B
    3RD EUROPEAN CONGRESS OF EPILEPTOLOGY, 1998, : 45 - 48
  • [2] TOTAL AND FREE VALPROIC ACID - PLASMA-LEVEL DOSE RATIO IN MONOTHERAPY
    ABADIN, JA
    DURAN, JA
    SANCHEZ, A
    SERRANO, JS
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1991, 13 (03): : 221 - 225
  • [3] TOTAL AND FREE VALPROIC ACID - PLASMA-LEVEL DOSE RATIO IN MONOTHERAPY
    DURAN, JA
    ABADIN, JA
    TORELLO, J
    SERRANO, JS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2380 - 2380
  • [4] Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy
    Sundqvist, A
    Tomson, T
    Lundkvist, B
    THERAPEUTIC DRUG MONITORING, 1997, 19 (02) : 153 - 159
  • [5] VALPROIC ACID FREE FRACTION IN EPILEPTIC CHILDREN UNDER CHRONIC MONOTHERAPY
    RIVA, R
    ALBANI, F
    FRANZONI, E
    PERUCCA, E
    SANTUCCI, M
    BARUZZI, A
    THERAPEUTIC DRUG MONITORING, 1983, 5 (02) : 197 - 200
  • [6] EMIT TOTAL AND FREE VALPROIC ACID USING THE FLEXIGEM
    MCADOO, CA
    HOWANITZ, JH
    HOWANITZ, PJ
    RAUER, SD
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1276 - 1276
  • [7] PHARMACOKINETICS OF FREE AND TOTAL FLUCLOXACILIN IN NEWBORN-INFANTS
    HERNGREN, L
    EHRNEBO, M
    BROBERGER, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (04) : 403 - 409
  • [8] PSEUDOATROPHY OF THE BRAIN WITH VALPROIC ACID MONOTHERAPY
    MCLACHLAN, RS
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 294 - 296
  • [9] FREE PHENOBARBITAL AND VALPROIC ACID IN SERUM FROM CHILDREN UNDER CHRONIC MONOTHERAPY
    SADAHIRO, N
    KONISHI, H
    MATSUI, T
    YOKOYAMA, S
    KODAMA, S
    MATSUO, T
    BRAIN & DEVELOPMENT, 1986, 8 (02): : 165 - 165
  • [10] PHARMACOKINETICS OF VALPROIC ACID IN THE ELDERLY
    PERUCCA, E
    GRIMALDI, R
    GATTI, G
    PIRRACCHIO, S
    CREMA, F
    FRIGO, GM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) : 665 - 669